Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer
NCT07495098
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer Metastatic
Lung Cancer (NSCLC)
Interventions
DRUG:
cisplatin (cis-diamminedichloroplatinum(II) (CDDP))
Sponsor
University of Vermont